Clinical Trials

Showing 1166 Clinical Trials
Sort by:
  • Ketamine

    Phase 4

    Completed

  • Sodium Oxybate in Patients With Alternating Hemiplegia of Childhood (AHC-SO)

    Start Date: August 2022 Updated: March 2014

    Salt Lake City, Utah, USA

    GHB

    Phase 1|Phase 2

    Completed

  • Dose-escalation Study of Single Dose GHB04L1 in Healthy Adults

    Start Date: August 2022 Updated: March 2010

    Vienna, Austria

    GHB

    Phase 1

    Completed

  • Sodium Oxybate in the Treatment of Binge Eating Disorder

    Start Date: August 2022 Updated: June 2011

    Mason, Ohio, USA

    GHB

    Phase 2|Phase 3

    Completed

  • A Safety and Efficacy Study of Xyrem in Subjects With Fibromyalgia

    Start Date: August 2022 Updated: December 2011

    Austin, Texas, USA
    Houston, Texas, USA
    Sacramento, California, USA
    San Antonio, Texas, USA
    Santa Barbara, California, USA
    Salt Lake City, Utah, USA
    Eugene, Oregon, USA
    Indianapolis, Indiana, USA
    Phoenix, Arizona, USA
    Durham, North Carolina, USA
    Winston-Salem, North Carolina, USA
    Charleston, South Carolina, USA
    Pasadena, California, USA
    Santa Ana, California, USA
    Peoria, Illinois, USA
    Lexington, Kentucky, USA
    Lansing, Michigan, USA
    Omaha, Nebraska, USA
    Charlotte, North Carolina, USA
    Oklahoma City, Oklahoma, USA
    Greer, South Carolina, USA
    Chattanooga, Tennessee, USA
    Madisonville, Kentucky, USA
    Springfield, Massachusetts, USA
    Berlin, New Jersey, USA
    Columbus, Ohio, USA
    Fort Worth, Texas, USA
    Rochester, New York, USA
    Orlando, Florida, USA
    Albany, New York, USA
    St. Louis, Missouri, USA
    Springfield, Missouri, USA
    Fort Lauderdale, Florida, USA
    Worcester, Massachusetts, USA
    Edison, New Jersey, USA
    Bowling Green, Kentucky, USA
    Raleigh, North Carolina, USA
    Anniston, Alabama, USA
    Renton, Washington, USA
    Anaheim, California, USA
    Pismo Beach, California, USA
    Fort Meyers, Florida, USA
    Mechanicsburg, Pennsylvania, USA
    Carmichael, California, USA
    Plantation, Florida, USA
    Gurnee, Illinois, USA
    Cherry Hill, New Jersey, USA
    Mogadore, Ohio, USA
    Tulsa, Oklahoma, USA
    Warwick, Rhode Island, USA
    Knoxville, Tennessee, USA
    Kirkland, Washington, USA
    Charleston, West Virginia, USA
    Burbank, California, USA
    Largo, Florida, USA
    Westfield, New York, USA
    Evansville, Indiana, USA
    Huntsville, Alabama, USA
    Whittier, California, USA
    Port Orange, Florida, USA
    Middletown, Ohio, USA
    Perrysburg, Ohio, USA
    Medford, Oregon, USA

    GHB

    Phase 3

    Completed

  • Xyrem for Treatment Refractory Insomnia Due to PTSD

    Start Date: August 2022 Updated: September 2012

    Syracuse, New York, USA

    GHB

    Phase 2

    Withdrawn

  • Physiological, Behavioral and Subjective Effects of Drugs (GHB)

    Start Date: August 2022 Updated: September 2008

    Baltimore, Maryland, USA

    GHB

    Phase 1

    Completed

  • MDMA

    Phase 2

    Withdrawn

  • Exploratory Study of Low Dose Psilocybin

    Start Date: August 2022 Updated: May 2022

    Psilocybin

    Early Phase 1

    Not yet recruiting

  • Psilocybin-facilitated Treatment for Chronic Pain

    Start Date: August 2022 Updated: May 2022

    Psilocybin

    Early Phase 1

    Not yet recruiting